These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7690735)

  • 1. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
    Hage C; Willman CL; Favara BE; Isaacson PG
    Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
    Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
    J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation.
    de Graaf JH; Tamminga RY; Kamps WA; Timens W
    Am J Pathol; 1994 Mar; 144(3):466-72. PubMed ID: 7510455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of macrophage-associated antigens in tissues involved by Langerhans' cell histiocytosis (histiocytosis X).
    Ruco LP; Pulford KA; Mason DY; Ceccamea A; Uccini S; Pileri S; Baglioni P; Baroni CD
    Am J Clin Pathol; 1989 Sep; 92(3):273-9. PubMed ID: 2788988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Foss HD; Herbst H; Araujo I; Hummel M; Berg E; Schmitt-Gräff A; Stein H
    J Pathol; 1996 May; 179(1):60-5. PubMed ID: 8691347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x).
    Ornvold K; Ralfkiaer E; Carstensen H
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(5):403-10. PubMed ID: 2107627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
    Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
    Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte sub-populations and non-Langerhans' cell monocytoid cells in pulmonary Langerhans' cell histiocytosis.
    Nagarjun Rao R; Chang CC; Tomashefski JF
    Pathol Res Pract; 2008; 204(5):315-22. PubMed ID: 18337020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.
    Paulli M; Feller AC; Boveri E; Kindl S; Berti E; Rosso R; Merz H; Facchetti F; Gambini C; Bonetti F
    Virchows Arch; 1994; 424(6):601-6. PubMed ID: 8055153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Lymphocytes bearing the gamma delta T-cell receptor in cutaneous lesions of Langerhans' cell histiocytosis.
    Alaibac M; Chu AC
    Med Pediatr Oncol; 1993; 21(5):347-9. PubMed ID: 8492749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
    Lau SK; Chu PG; Weiss LM
    Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic phenotype of Langerhans cell histiocytosis: an immunohistochemical study demonstrating the value of LN-2, LN-3, and vimentin.
    Azumi N; Sheibani K; Swartz WG; Stroup RM; Rappaport H
    Hum Pathol; 1988 Dec; 19(12):1376-82. PubMed ID: 2973428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of adhesion molecules in Langerhans' cell histiocytosis.
    Ruco LP; Stoppacciaro A; Vitolo D; Uccini S; Baroni CD
    Histopathology; 1993 Jul; 23(1):29-37. PubMed ID: 7690006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 expression in Langerhans' cell histiocytosis.
    Savell VH; Sherman T; Scheuermann RH; Siddiqui AM; Margraf LR
    Pediatr Dev Pathol; 1998; 1(3):210-5. PubMed ID: 10463280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
    Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
    Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study on antigenic phenotype of Langerhans cell histiocytosis.
    Yang WI
    Yonsei Med J; 1992 Dec; 33(4):309-19. PubMed ID: 1285018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosis.
    Emile JF; Peuchmaur M; Fraitag S; Bodemer C; Brousse N
    Histopathology; 1993 Oct; 23(4):327-32. PubMed ID: 7507881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prominent Langerhans' cell migration in the arthropod bite reactions simulating Langerhans' cell histiocytosis.
    Kim SH; Kim DH; Lee KG
    J Cutan Pathol; 2007 Dec; 34(12):899-902. PubMed ID: 18001411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adult xanthogranuloma with a small portion of BRAF
    Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
    Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.